Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
QCLS on Nasdaq
Shares outstanding
11,453,200
Price per share
$4.51
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
371,920
Total reported value
$1,483,958
% of total 13F portfolios
0%
Share change
+355,536
Value change
+$1,416,985
Number of holders
12
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PharmaCyte Biotech, Inc. 74% $28,646,744 8,475,368 PharmaCyte Biotech, Inc. 14 Nov 2025

As of 31 Dec 2025, 12 institutional investors reported holding 371,920 shares of Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS). This represents 3.2% of the company’s total 11,453,200 outstanding shares.

Institutional Holders of Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 371,920 $1,483,958 +$1,416,985 $3.99 12
2025 Q3 16,820 $69,803 +$69,803 $4.15 11